1-Hydroxybenzotriazole → HCID 46926698, 화합물

HRID 877036노트

반응식

HRID 877036 반응식
[CH3:1][N:2]1[C:7]2=[CH:8][S:9][C:10](C)=[C:6]2[C:5](=[O:12])[N:4]([CH3:13])[C:3]1=[O:14].[Cl:15][C:16]1[CH:17]=[C:18]([C:23]2[N:24]=[C:25]([NH2:28])[S:26][CH:27]=2)[CH:19]=[CH:20][C:21]=1[Cl:22].CCN=C=NC[CH2:35][CH2:36]N(C)C.Cl.C1C=CC2N([OH:50])N=NC=2C=1>CN(C1C=CN=CC=1)C.ClCCCl>[Cl:15][C:16]1[CH:17]=[C:18]([C:23]2[N:24]=[C:25]([NH:28][C:35](=[O:50])[CH2:36][C:7]3[C:6]4[C:5](=[O:12])[N:4]([CH3:13])[C:3](=[O:14])[N:2]([CH3:1])[C:10]=4[S:9][CH:8]=3)[S:26][CH:27]=2)[CH:19]=[CH:20][C:21]=1[Cl:22]

참가 물질

7

실험 절차

The title compound was prepared according to the general procedure (Method A) by coupling Intermediate 1 (100 mg, 0.393 mmol) with 4-(3,4-dichlorophenyl)-1,3-thiazol-2-amine (96.5 mg, 0.393 mmol) in the presence of EDCI hydrochloride (90 mg, 0.471 mmol), HOBt (16 mg, 0.118 mmol) and DMAP (5 mg, 0.039 mmol) in 1,2 dichloroethane (4 ml) to give 40 mg of the product as a white solid; 1H NMR (300 MHz, DMSO-d6) δ 3.19 (s, 3H), 3.47 (s, 3H), 4.06 (s, 2H), 7.07 (s, 1H), 7.70 (d, J=8.4 Hz, 1H), 7.80 (s, 1H), 7.89 (d, J=6.9 Hz, 1H), 8.14 (s, 1H), 12.43 (br s, 1H); APCI-MS (m/z) 479.32 (M−H)+.

출처 및 근거

ORD 기록
ord-733c125ceb4d48dd9d557660f5015169
출처 데이터셋
uspto-grants-2015_03
특허 번호
US08987278B2

반응 노트

불러오는 중…